Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) issued an announcement. Recently, the company received approval from the China Drug Administration (hereinafter referred to as the “State Drug Administration”) to issue a “Drug Clinical Trial Approval Notice” for HRS-7172 tablets, and will conduct clinical trials in the near future.

Zhitongcaijing · 09/02/2025 12:49
Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) issued an announcement. Recently, the company received approval from the China Drug Administration (hereinafter referred to as the “State Drug Administration”) to issue a “Drug Clinical Trial Approval Notice” for HRS-7172 tablets, and will conduct clinical trials in the near future.